We’ve made extraordinary progress in healthcare. However, outcomes depend on whether people can make treatment work in their ...
Health technology firm myTomorrows and Rare Disease Research (RDR) have announced a US-based collaboration to improve patient ...
Biogen has entered into an agreement with TJ Biopharma (TJ Bio) to acquire exclusive rights to felzartamab in the Greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results